Related Experiment Video
Updated: Oct 7, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
The association of free testosterone levels with coronavirus disease 2019
Tugce Apaydin1, Bahadır Sahin2, Saida Dashdamirova1
1Department of Endocrinology and Metabolism, Marmara University School of Medicine, Istanbul, Turkey.
Background:
Angiotensin-converting enzyme 2 and transmembrane protease serine 2 are critical factors of virus transmission. Expression of angiotensin-converting enzyme 2 is highest in testes, and testicular function and testosterone levels were affected by coronavirus disease 2019. Low testosterone levels are related to infections, especially respiratory tract infections, and could worsen clinical conditions by exacerbating cytokine storms and increasing pro-inflammatory cytokines.
Objectives:
We aimed to evaluate the acute and chronic effects of coronavirus disease 2019 on gonadal functions. Our second aim was to detect the relationship between free testosterone levels and disease prognosis and determine the impact of low-free testosterone on admission to the intensive care unit.
Methods:
Eighty-one patients with reverse-transcription polymerase chain reaction-confirmed coronavirus disease 2019 were enrolled. Twenty-nine patients were assessed again for 6 months post-coronavirus disease 2019 follow-up, and seven of them had a semen analysis. Serum follicle-stimulating hormone, luteinizing hormone, sex hormone-binding globulin, and total testosterone levels were measured.
Results:
In this observational study, 71.6% (n = 58) of patients had low free testosterone levels at baseline, in which 69% were considered secondary hypogonadism. A longer length of hospitalization and increased inflammatory markers (d-dimer, high-sensitive C-reactive protein, and procalcitonin) were detected in the low-free testosterone group. Follicle-stimulating hormone, total, free, and bioavailable testosterone levels were lower in patients who required admission to the intensive care unit. Free testosterone levels were inversely correlated with the length of hospitalization and prognostic disease factors. Oligozoospermia and impaired progressive motility were present in 42.8% (3/7) of the patients. In 6 months post-coronavirus disease 2019 follow-up, out of 29 patients, 48.2% still had low testosterone levels.
Conclusion:
A high rate of hypogonadism (71.6%) was found, especially secondary hypogonadism, and about half of the patients had hypogonadism in the sixth months' follow-up. Low free testosterone levels were correlated with inflammatory parameters, and it is related to the intensive care unit admission. Studies with long-term follow-up data in larger groups are needed to determine persistent hypogonadism and impaired spermatogenesis.
Insights
Coronavirus disease 2019 significantly impacts male reproductive health, causing widespread hypogonadism and low testosterone. These hormonal changes correlate with disease severity and may persist long-term, affecting fertility.
Area of Science:
- Endocrinology
- Virology
- Reproductive Health
Background:
- Angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) are key to SARS-CoV-2 entry.
- ACE2 expression is highest in testes, suggesting potential testicular impact from COVID-19.
- Low testosterone is linked to infections, potentially worsening COVID-19 outcomes via cytokine storms.
Purpose of the Study:
- To assess acute and chronic effects of COVID-19 on male gonadal function.
- To investigate the relationship between free testosterone levels and COVID-19 prognosis.
- To determine if low free testosterone impacts intensive care unit (ICU) admission rates.
Main Methods:
- Observational study of 81 RT-PCR confirmed COVID-19 patients.
- Measurement of serum hormones including FSH, LH, SHBG, and total testosterone.
- Follow-up assessments at 6 months for 29 patients, including semen analysis for 7.
Main Results:
- 71.6% of patients presented with low free testosterone (secondary hypogonadism in 69%).
- Low testosterone group showed longer hospitalization and higher inflammatory markers (d-dimer, hs-CRP, procalcitonin).
- ICU-admitted patients had lower testosterone levels; free testosterone inversely correlated with hospitalization length and disease severity. Oligozoospermia and impaired motility observed in 42.8% of semen analyses.
Conclusions:
- High prevalence of hypogonadism (71.6%) observed in COVID-19 patients, with persistent issues in ~50% at 6 months.
- Low free testosterone is associated with inflammation and increased ICU admission risk.
- Further long-term studies are needed to clarify persistent hypogonadism and spermatogenesis impairment.
Related Concept Videos
Testosterone: Functions and Regulation
Infertility in Males

